HEADER TRANSFERASE/TRANSFERASE INHIBITOR 24-APR-13 4KC1 TITLE STRUCTURE OF THE BLOOD GROUP GLYCOSYLTRANSFERASE AAGLYB IN COMPLEX TITLE 2 WITH A PYRIDINE INHIBITOR AS A NEUTRAL PYROPHOSPHATE SURROGATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: FUCOSYLGLYCOPROTEIN ALPHA-N- COMPND 3 ACETYLGALACTOSAMINYLTRANSFERASE; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: FUCOSYLGLYCOPROTEIN 3-ALPHA-GALACTOSYLTRANSFERASE, COMPND 6 GLYCOPROTEIN-FUCOSYLGALACTOSIDE ALPHA-N- COMPND 7 ACETYLGALACTOSAMINYLTRANSFERASE, GLYCOPROTEIN-FUCOSYLGALACTOSIDE COMPND 8 ALPHA-GALACTOSYLTRANSFERASE, HISTO-BLOOD GROUP A TRANSFERASE, A COMPND 9 TRANSFERASE, HISTO-BLOOD GROUP B TRANSFERASE, B TRANSFERASE, NAGAT; COMPND 10 EC: 2.4.1.40, 2.4.1.37; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ABO; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS GTA SUPERFANILY, BLOOD GROUP PROTEINS, GLYCOSYLTRANSFERASE, FUC-GAL, KEYWDS 2 ADP-GAL, ADP-GALNAC, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.A.CUESTA-SEIJO,S.WANG,D.LAFONT,S.VIDAL,M.M.PALCIC REVDAT 3 15-NOV-17 4KC1 1 REMARK REVDAT 2 04-MAR-15 4KC1 1 JRNL REVDAT 1 11-SEP-13 4KC1 0 JRNL AUTH S.WANG,J.A.CUESTA-SEIJO,D.LAFONT,M.M.PALCIC,S.VIDAL JRNL TITL DESIGN OF GLYCOSYLTRANSFERASE INHIBITORS: PYRIDINE AS A JRNL TITL 2 PYROPHOSPHATE SURROGATE. JRNL REF CHEMISTRY V. 19 15346 2013 JRNL REFN ISSN 0947-6539 JRNL PMID 24108680 JRNL DOI 10.1002/CHEM.201301871 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : REFMAC 5 DICTIONARY REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.30 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 51219 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.142 REMARK 3 R VALUE (WORKING SET) : 0.141 REMARK 3 FREE R VALUE : 0.181 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1537 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.54 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3608 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2070 REMARK 3 BIN FREE R VALUE SET COUNT : 112 REMARK 3 BIN FREE R VALUE : 0.2630 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2362 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 405 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.35 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.67000 REMARK 3 B22 (A**2) : -0.15000 REMARK 3 B33 (A**2) : 0.82000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.077 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.067 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.041 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.472 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.972 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.960 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2682 ; 0.006 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3675 ; 1.117 ; 1.975 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 339 ; 5.646 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 133 ;32.700 ;22.481 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 466 ;12.264 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 27 ;15.626 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 401 ; 0.080 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2068 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1213 ; 0.728 ; 1.251 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1530 ; 0.946 ; 1.881 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1468 ; 1.018 ; 1.436 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 2681 ; 0.875 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 94 ;42.919 ; 5.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 2898 ;13.437 ; 5.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT U VALUES: REFINED INDIVIDUALLY REMARK 4 REMARK 4 4KC1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-APR-13. REMARK 100 THE DEPOSITION ID IS D_1000079148. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-JUL-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.873 REMARK 200 MONOCHROMATOR : SI 111 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51220 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.08500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.4700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.58700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.990 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLECULAR REPALCEMENT REMARK 200 STARTING MODEL: PDB ENTRY 3IOI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.61 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 13% OR 15% PEG 3350, 50 MM OR 150 MM REMARK 280 AMMONIUM SULFATE AND 50 MM MOPS PH 7, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293K, PH 7.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 40.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 26.42500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 74.93500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 26.42500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 74.93500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 40.00000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 26.42500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 74.93500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 40.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 26.42500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 74.93500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5180 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23190 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -36.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -40.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 594 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 712 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 57 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 63 CG SD CE REMARK 470 LYS A 346 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 62 127.07 -36.70 REMARK 500 LYS A 124 -124.68 55.51 REMARK 500 ARG A 199 -42.72 -145.07 REMARK 500 THR A 245 45.88 -88.19 REMARK 500 PHE A 269 100.62 -162.13 REMARK 500 HIS A 301 -131.81 59.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN A 401 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 213 OD2 REMARK 620 2 WS1 A 403 O13 97.5 REMARK 620 3 HOH A 501 O 102.0 81.7 REMARK 620 4 WS1 A 403 N19 102.2 72.1 146.2 REMARK 620 5 HOH A 619 O 172.9 89.6 78.1 80.8 REMARK 620 6 HOH A 735 O 80.3 150.0 69.7 137.8 93.1 REMARK 620 7 WS1 A 403 O21 84.7 137.7 139.4 66.2 90.6 72.2 REMARK 620 N 1 2 3 4 5 6 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MN A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BHE A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE WS1 A 403 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4KC4 RELATED DB: PDB REMARK 900 STRUCTURE OF THE SAME PROTEIN WITH A RELATED SYNTHETIC INHIBITOR REMARK 900 RELATED ID: 4KC2 RELATED DB: PDB REMARK 900 STRUCTURE OF THE SAME PROTEIN WITH A RELATED SYNTHETIC INHIBITOR REMARK 999 REMARK 999 SEQUENCE REMARK 999 GLY266 AND ALA268 ARE THE CORRECT IDENTITIES AT THIS POSITION. REMARK 999 THESE TWO MUTATIONS MAKE THE PROTEIN A HYBRID BETWEEN THE GTA AND REMARK 999 GTB BLOOD GROUP PROTEINS DBREF 4KC1 A 64 346 UNP P16442 BGAT_HUMAN 64 346 SEQADV 4KC1 MET A 57 UNP P16442 EXPRESSION TAG SEQADV 4KC1 ALA A 58 UNP P16442 EXPRESSION TAG SEQADV 4KC1 ILE A 59 UNP P16442 EXPRESSION TAG SEQADV 4KC1 GLY A 60 UNP P16442 EXPRESSION TAG SEQADV 4KC1 GLU A 61 UNP P16442 EXPRESSION TAG SEQADV 4KC1 PHE A 62 UNP P16442 EXPRESSION TAG SEQADV 4KC1 MET A 63 UNP P16442 EXPRESSION TAG SEQADV 4KC1 GLY A 266 UNP P16442 LEU 266 SEE REMARK 999 SEQADV 4KC1 ALA A 268 UNP P16442 GLY 268 SEE REMARK 999 SEQRES 1 A 290 MET ALA ILE GLY GLU PHE MET VAL SER LEU PRO ARG MET SEQRES 2 A 290 VAL TYR PRO GLN PRO LYS VAL LEU THR PRO CYS ARG LYS SEQRES 3 A 290 ASP VAL LEU VAL VAL THR PRO TRP LEU ALA PRO ILE VAL SEQRES 4 A 290 TRP GLU GLY THR PHE ASN ILE ASP ILE LEU ASN GLU GLN SEQRES 5 A 290 PHE ARG LEU GLN ASN THR THR ILE GLY LEU THR VAL PHE SEQRES 6 A 290 ALA ILE LYS LYS TYR VAL ALA PHE LEU LYS LEU PHE LEU SEQRES 7 A 290 GLU THR ALA GLU LYS HIS PHE MET VAL GLY HIS ARG VAL SEQRES 8 A 290 HIS TYR TYR VAL PHE THR ASP GLN PRO ALA ALA VAL PRO SEQRES 9 A 290 ARG VAL THR LEU GLY THR GLY ARG GLN LEU SER VAL LEU SEQRES 10 A 290 GLU VAL ARG ALA TYR LYS ARG TRP GLN ASP VAL SER MET SEQRES 11 A 290 ARG ARG MET GLU MET ILE SER ASP PHE CYS GLU ARG ARG SEQRES 12 A 290 PHE LEU SER GLU VAL ASP TYR LEU VAL CYS VAL ASP VAL SEQRES 13 A 290 ASP MET GLU PHE ARG ASP HIS VAL GLY VAL GLU ILE LEU SEQRES 14 A 290 THR PRO LEU PHE GLY THR LEU HIS PRO GLY PHE TYR GLY SEQRES 15 A 290 SER SER ARG GLU ALA PHE THR TYR GLU ARG ARG PRO GLN SEQRES 16 A 290 SER GLN ALA TYR ILE PRO LYS ASP GLU GLY ASP PHE TYR SEQRES 17 A 290 TYR GLY GLY ALA PHE PHE GLY GLY SER VAL GLN GLU VAL SEQRES 18 A 290 GLN ARG LEU THR ARG ALA CYS HIS GLN ALA MET MET VAL SEQRES 19 A 290 ASP GLN ALA ASN GLY ILE GLU ALA VAL TRP HIS ASP GLU SEQRES 20 A 290 SER HIS LEU ASN LYS TYR LEU LEU ARG HIS LYS PRO THR SEQRES 21 A 290 LYS VAL LEU SER PRO GLU TYR LEU TRP ASP GLN GLN LEU SEQRES 22 A 290 LEU GLY TRP PRO ALA VAL LEU ARG LYS LEU ARG PHE THR SEQRES 23 A 290 ALA VAL PRO LYS HET MN A 401 1 HET BHE A 402 32 HET WS1 A 403 27 HETNAM MN MANGANESE (II) ION HETNAM BHE OCTYL 2-O-(6-DEOXY-ALPHA-L-GALACTOPYRANOSYL)-BETA-D- HETNAM 2 BHE GALACTOPYRANOSIDE HETNAM WS1 6-(1-BETA-D-GLUCOPYRANOSYLOXYMETHYL)-N-(5'- HETNAM 2 WS1 DEOXYLURIDINE-5'-YL)PICOLINAMIDE HETSYN BHE H-ANTIGEN ACCEPTOR; ALPHA-L-FUCP-(1,2)-BETA-D-GALP- HETSYN 2 BHE O(CH2)7CH3 FORMUL 2 MN MN 2+ FORMUL 3 BHE C20 H38 O10 FORMUL 4 WS1 C22 H28 N4 O12 FORMUL 5 HOH *405(H2 O) HELIX 1 1 ASN A 101 LEU A 111 1 11 HELIX 2 2 ILE A 123 ALA A 128 5 6 HELIX 3 3 PHE A 129 PHE A 141 1 13 HELIX 4 4 GLN A 155 VAL A 159 5 5 HELIX 5 5 ARG A 180 ARG A 187 1 8 HELIX 6 6 ARG A 187 ARG A 199 1 13 HELIX 7 7 ARG A 199 VAL A 204 1 6 HELIX 8 8 GLY A 221 LEU A 225 5 5 HELIX 9 9 SER A 240 PHE A 244 5 5 HELIX 10 10 VAL A 274 ASN A 294 1 21 HELIX 11 11 TRP A 300 HIS A 313 1 14 HELIX 12 12 PRO A 321 LEU A 324 5 4 HELIX 13 13 ASP A 326 GLY A 331 1 6 SHEET 1 A 8 ILE A 94 VAL A 95 0 SHEET 2 A 8 LYS A 317 LEU A 319 1 O VAL A 318 N VAL A 95 SHEET 3 A 8 LEU A 228 THR A 231 1 N GLY A 230 O LEU A 319 SHEET 4 A 8 PHE A 269 SER A 273 -1 O GLY A 271 N PHE A 229 SHEET 5 A 8 TYR A 206 VAL A 210 -1 N CYS A 209 O PHE A 270 SHEET 6 A 8 THR A 115 ALA A 122 1 N GLY A 117 O TYR A 206 SHEET 7 A 8 ARG A 146 THR A 153 1 O PHE A 152 N ALA A 122 SHEET 8 A 8 ARG A 168 GLU A 174 1 O GLN A 169 N TYR A 149 SHEET 1 B 2 MET A 214 PHE A 216 0 SHEET 2 B 2 PHE A 341 ALA A 343 -1 O THR A 342 N GLU A 215 LINK OD2 ASP A 213 MN MN A 401 1555 1555 2.20 LINK MN MN A 401 O13 WS1 A 403 1555 1555 2.25 LINK MN MN A 401 O HOH A 501 1555 1555 2.29 LINK MN MN A 401 N19 WS1 A 403 1555 1555 2.31 LINK MN MN A 401 O HOH A 619 1555 1555 2.32 LINK MN MN A 401 O HOH A 735 1555 1555 2.42 LINK MN MN A 401 O21 WS1 A 403 1555 1555 2.47 SITE 1 AC1 5 ASP A 213 WS1 A 403 HOH A 501 HOH A 619 SITE 2 AC1 5 HOH A 735 SITE 1 AC2 18 HIS A 233 GLY A 235 PHE A 236 THR A 245 SITE 2 AC2 18 TRP A 300 GLU A 303 ASP A 326 WS1 A 403 SITE 3 AC2 18 HOH A 583 HOH A 619 HOH A 665 HOH A 673 SITE 4 AC2 18 HOH A 719 HOH A 721 HOH A 758 HOH A 772 SITE 5 AC2 18 HOH A 786 HOH A 831 SITE 1 AC3 20 PHE A 121 ALA A 122 ILE A 123 TYR A 126 SITE 2 AC3 20 VAL A 184 ARG A 188 ASP A 211 VAL A 212 SITE 3 AC3 20 ASP A 213 MN A 401 BHE A 402 HOH A 501 SITE 4 AC3 20 HOH A 525 HOH A 613 HOH A 619 HOH A 620 SITE 5 AC3 20 HOH A 638 HOH A 735 HOH A 831 HOH A 898 CRYST1 52.850 149.870 80.000 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018921 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006672 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012500 0.00000 MASTER 346 0 3 13 10 0 12 6 0 0 0 23 END